Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest T Hawk

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|July 5, 2023
From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited ArticlesKaren Colbert Maresso, Anirban Maitra, Ernest T Hawk, et al.
The Medical Clinics of North America|November 6, 2004
Prevention and therapy of colorectal cancerErnest T Hawk, Asad Umar, Ellen Richmond, et al.
American Journal of Clinical Oncology|August 7, 2003
Development of COX inhibitors in cancer prevention and therapyAsad Umar, Jaye L Viner, William F Anderson, et al.
Nature Reviews. Cancer|February 18, 2004
Testing guidelines for hereditary non-polyposis colorectal cancerAsad Umar, John I Risinger, Ernest T Hawk, et al.
Current Pharmaceutical Design|April 12, 2002
The role of cyclooxygenase inhibitors in cancer preventionWilliam F Anderson, Asad Umar, Jaye L Viner, et al.
Seminars in Oncology|March 13, 2016
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer preventionAsad Umar, Vernon E Steele, David G Menter, et al.
Journal of the National Cancer Institute|April 18, 2002
COX-2 in cancer--a player that's defining the rulesErnest T Hawk, Jaye L Viner, Andrew Dannenberg, et al.
Mutation Research|March 12, 2003
Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancerVernon E Steele, Ernest T Hawk, Jaye L Viner, et al.
International Journal of Clinical Oncology|April 11, 2002
Chemoprevention of colorectal carcinogenesisAsad Umar, Jaye L Viner, Ellen Richmond, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 15, 2005
Can animal models help us select specific compounds for cancer prevention trials?Ernest T Hawk, Asad Umar, Ronald A Lubet, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Cancer Prevention Research (Philadelphia, Pa.)|July 5, 2023
From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited ArticlesKaren Colbert Maresso, Anirban Maitra, Ernest T Hawk, et al.
The Medical Clinics of North America|November 6, 2004
Prevention and therapy of colorectal cancerErnest T Hawk, Asad Umar, Ellen Richmond, et al.
American Journal of Clinical Oncology|August 7, 2003
Development of COX inhibitors in cancer prevention and therapyAsad Umar, Jaye L Viner, William F Anderson, et al.
Nature Reviews. Cancer|February 18, 2004
Testing guidelines for hereditary non-polyposis colorectal cancerAsad Umar, John I Risinger, Ernest T Hawk, et al.
Current Pharmaceutical Design|April 12, 2002
The role of cyclooxygenase inhibitors in cancer preventionWilliam F Anderson, Asad Umar, Jaye L Viner, et al.
Seminars in Oncology|March 13, 2016
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer preventionAsad Umar, Vernon E Steele, David G Menter, et al.
Journal of the National Cancer Institute|April 18, 2002
COX-2 in cancer--a player that's defining the rulesErnest T Hawk, Jaye L Viner, Andrew Dannenberg, et al.
Mutation Research|March 12, 2003
Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancerVernon E Steele, Ernest T Hawk, Jaye L Viner, et al.
International Journal of Clinical Oncology|April 11, 2002
Chemoprevention of colorectal carcinogenesisAsad Umar, Jaye L Viner, Ellen Richmond, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 15, 2005
Can animal models help us select specific compounds for cancer prevention trials?Ernest T Hawk, Asad Umar, Ronald A Lubet, et al.
Pageof 10